BlinkLab App Study for Autism Diagnosis in Children
Online Evaluation of the Diagnostic Accuracy of BlinkLab's Digital Assessments for Autism
Recruiting
Observational Study
Autism
Autism Spectrum Disorder
Autism Spectrum Disorder (ASD)
Neurodevelopmental Conditions
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 2 – 11
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Blinklab Limited · Industry
Who this trial is looking for
This trial is looking for children ages 2 to 11 who have had a recent neurodevelopmental assessment. Participants will use a smartphone app to complete two short video sessions and answer some questions about their development.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 2 to 11 years old
- I have had a neurodevelopmental assessment in the past 12 months
- I can read and understand English
- I can give my consent to take part
- I am willing to be videotaped during the sessions
You may not be able to join if
- I do not have a smartphone to use the app
- I have been part of a BlinkLab clinical study before
- I cannot complete the study sessions from home in the US
- I have a history of seizures caused by sounds
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This observational study aims to evaluate how patterns of behavioral and sensorimotor responses measured using the BlinkLab Dx1 smartphone application relate to autism diagnoses in children ages 2 to 11. BlinkLab Dx1 is a non-invasive, smartphone-based application under development as a diagnostic aid for healthcare providers assessing autism.
In this study, children who have undergone a neurodev…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age: Children between 2 to 11 years old
2. Parent/Caregiver/Healthcare Provider Concern: The child has received a diagnostic outcome of a neurodevelopmental assessment based on DSM-5 criteria within the past 12 months.
3. Language Proficiency: Parents and subjects must have f…
Contacts